Stock Price Quote

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE919.00-25.6 (-2.71 %)
PREV CLOSE ( ) 944.60
OPEN PRICE ( ) 940.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13255
TODAY'S LOW / HIGH ( )900.00 950.00
52 WK LOW / HIGH ( ) 635984
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-06 1987
Management Info
Daulat N Medhora - Chairman Fredun N Medhora - Managing Director
Registered Office

Address 11th Floor, Tower A,Urmi Estate 95, Ganpatrao Kadam Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone 022-40318111

Email business@fredungroup.com

Website www.fredungroup.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE

NEWS

01Jul Fredun Pharmaceuticals moves up as its
Fredun Pharmaceuticals is currently trading at Rs. 837.75, up by 7.30 po..
30Jun Fredun Pharmaceuticals’ arm acquires c
Fredun Pharmaceuticals’ (FPL) wholly owned subsidiary -- Fredun Retail (..
22May Fredun Pharmaceuticals informs about
Pursuant to Regulation 29 read with Regulation 33 of SEBI (Listing Oblig..
10Apr Fredun Pharmaceuticals secures tender
Fredun Pharmaceuticals has been awarded a tender by the Tamil Nadu Medic..
03Apr Fredun Pharmaceutical informs about pr
Fredun Pharmaceutical has informed that it enclosed press release titled..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit70.7199999999999208.08
Gross Profit 80.4199999999999 282.71
Operating Profit 174.39550.97
Net Sales 1674.084562.68

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Blue Jet Healthcare (BSE)
peergroup  1012.00 (4.21%)
M.Cap ( in Cr)17554.70
Jubilant Pharmova (BSE)
peergroup  1234.90 (2.87%)
M.Cap ( in Cr)19669.63
Mercury Laboratories (BSE)
peergroup  888.00 (3.71%)
M.Cap ( in Cr)106.56
Sanjivani Paranteral (BSE)
peergroup  247.40 (11.39%)
M.Cap ( in Cr)303.91
Abbott India (BSE)
peergroup  34148.85 (0.06%)
M.Cap ( in Cr)72563.92

Shareholding Pattern

NON-INSTITUTION 49.48%
PROMOTERS 48.93%
FI/BANKS/INSURANCE 1.59%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Fredun Pharmaceuticals Ltd.

Fredun Pharmaceuticals Ltd. was incorporated in the year 1987. Its today's share price is 919. Its current market capitalisation stands at Rs 433.92 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3481.56 Cr and Total Income of Rs.3490.72 Cr. The company's management includes Parag Ashok Goyal, Rohinton H Kanga, Daisy Dsouza, Aspi N Raimalwala, Fredun N Medhora, Daulat N Medhora, Daulat N Medhora.

It is listed on the BSE with a BSE Code of 539730 , NSE with an NSE Symbol of and ISIN of INE194R01017. It's Registered office is at 11th Floor, Tower A,Urmi Estate 95, Ganpatrao Kadam Marg,Lower Parel (West)Mumbai-400013, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are RH Nisar & Co, Salve & Co, Savla & Associates, VD Kandekar & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.